Performance comparison between packed column supercritical fluid chromatography (SFC) and HPLC using cyclandelate as the model analyteBHOIR, I. C; RAMAN, B; SUNDARESAN, M et al.Fresenius' journal of analytical chemistry. 1998, Vol 361, Num 2, pp 86-89, issn 0937-0633Article

DISTRIBUTION OF TRITIATED CYCLANDELATE (3, 5, 5-TRIMETHYLCYCLOHEXYL-MANDELATE); A VASOACTIVE DURG: PRELIMINARY OBSERVATIONS BY LIQUID SCINTILLATION SPECTROMETRY = LA REPARTITION DU CYCLANDELATE TRITIEE (MANDELATE DE TRIMETHYL-3,5,5 CYCLOHEXYLE), UN MEDICAMENT VASOACTIF: OBSERVATIONS PRELIMINAIRES PAR SCINTILLATION LIQUIDEORR A; WHITTIER JR.1974; INTERNATION. J. NUCL. MED. BIOL.; G.B.; DA. 1974; VOL. 1; NO 4; PP. 205-213; ABS. FR. ESP.; BIBL. 7REF.Article

EINE METHODE ZUR OBJEKTIVIERUNG DER PSYCHISCHEN LEISTUNGSVERAENDERUNG DURCH CYCLOSPASMOL = UNE METHODE DE TRAITEMENT OBJECTIF PAR LE CYCLOSPASMOLALTHAUS H; FONTANA B; PLASZCZYK A et al.1974; PRAXIS; SCHWEIZ; DA. 1974; VOL. 63; NO 41; PP. 1239-1242; ABS. ANGLArticle

A STUDY OF COMPOUNDS WHICH INHIBIT VASCULAR SMOOTH MUSCLE CONTRACTION = ETUDE DES COMPOSES QUI INHIBENT LA CONTRACTION DES MUSCLES LISSES DES VAISSEAUXMASSINGHAM R.1973; EUROP. J. PHARMACOL.; NETHERL.; DA. 1973; VOL. 22; NO 1; PP. 75-82; BIBL. 17 REF.Serial Issue

LE CYCLOSPASMOL 400 EN THERAPEUTIQUE PSYCHIATRIQUE.BORNSTEIN S; OGER P; DERAMOND F et al.1976; ACTUAL. PSYCHIATR.; FR.; DA. 1976; VOL. 6; NO 5; PP. 80-83Article

INTRAARTERIAL ADMINISTRATION OF EMULSION FORMULATIONS CONTAINING CYCLANDELATE AND NITROGLYCERINJEPPSSON R; LJUNGBERG S.1973; ACTA PHARM. SUECICA; SUEDE; DA. 1973; VOL. 10; NO 2; PP. 129-140; BIBL. 19REF.Serial Issue

DRUGS FOR DEMENTIA.1975; DRUG THERAPEUT. BULL.; G.B.; DA. 1975; VOL. 13; NO 22; PP. 85-87; BIBL. 35 REF.Article

Pathophysiology and psychopharmacology of dementia: A new study design. 2. Cyclandelate treatment - a placebo-controlled double-blind clinical trialSCHELLENBERG, R; TODOROVA, A; WEDEKIND, W et al.Neuropsychobiology. 1997, Vol 35, Num 3, pp 132-142, issn 0302-282XConference Paper

ACTION DU CYCLOSPASMOL 400 DANS LES SURDITES COCHLEAIRES.NEVEU M.1978; CAH. OTO-RHINO-LARYNGOL. CHIR. CERVICO-FACIALE; FRA; DA. 1978; VOL. 13; NO 5; PP. 527-531Article

CYCLANDELATE IN THE TREATMENT OF CEREBRAL ARTERIOSCLEROSISHALL P.1976; J. AMER. GERIATR. SOC.; U.S.A.; DA. 1976; VOL. 24; NO 1; PP. 41-45Article

High-performance liquid chromatographic method for the determination of a cyclandelate metabolite, mandelic acid, in human plasmaKOJIMA, K; UEZONO, Y; TAKAHASHI, T et al.Journal of chromatography. 1988, Vol 425, Num 1, pp 203-207, issn 0021-9673Article

CYCLANDELATE IN THE TREATMENT OF SENILITY: A CONTROLLED STUDYCAPOTE B; PARIKH N.1978; J. AMER. GERIATR. SOC.; USA; DA. 1978; VOL. 26; NO 8; PP. 360-362; BIBL. 10 REF.Article

THE EFFECT OF CYCLANDELATE IN DEPRESSED AND DEMENTED PATIENTS: A CONTROLLED STUDY IN PSYCHOGERIATRIC PATIENTS.DAVIES G; HAMILTON S; HENDRICKSON E et al.1977; AGE AND AGEING; G.B.; DA. 1977; VOL. 6; NO 3; PP. 156-162; BIBL. 18 REF.Article

Etude clinique contrôlée de Novodil^® dans le traitement des lésions maculaires séniles = Clinical study of Novodil in treatment of macular lesionsDELAFOULHOUJE, C; SOLE, P; DALENS, H et al.Bulletin des sociétés d'ophtalmologie de France. 1985, Vol 85, Num 10, pp 1065-1067, issn 0081-1270Article

Cyclandelat und analoge Verbindungen = Cyclandelate and analogous compoundsUNTERHALT, B; GORES, P.Archiv der Pharmazie (Weinheim). 1990, Vol 323, Num 4, pp 211-213, issn 0365-6233, 3 p.Article

Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraineMASTROSIMONE, F; IACCARINO, C; DE CATERINA, G et al.Journal of medicine (Westbury). 1992, Vol 23, Num 1, pp 1-16, issn 0025-7850Article

Dosage plasmatique et urinaire du 3,3,5-triméthylcyclohexanol-cis libre et conjugué = Determination of free and conjugated cis-3,3,5-triméthylcyclohexanol in plasma and urineANDERMANN, G; DIETZ, M.Journal of chromatography. 1983, Vol 272, Num 2, pp 299-305, issn 0021-9673Article

ETUDE DE LA BIODISPONIBILITE DE MEDICAMENTS A BASE DE CYCLANDELATEANDERMANN G; DIETZ M; MERGEL D et al.1979; PHARM. ACTA HELV.; CHE; DA. 1979; VOL. 54; NO 12; PP. 366-369; BIBL. 12 REF.Article

CIRCULATORY EFFECT OF SEVERAL CEREBRAL CIRCULATORY DRUGS IN MAN, WITH SPECIAL REFERENCE TO AMINOPHYLLINE, PAPAVERINE, CYCLANDELATE, VINCAMINE, PROSTAGLANDIN E₁ AND ISOXSUPRINEMIYAZAKI M.1978; JAP. CIRCUL. J.; JPN; DA. 1978; VOL. 42; NO 4; PP. 433-440; BIBL. 20 REF.Article

TREATMENT OF EARLY DIABETIC RETINOPATHY WITH CYCLANDELATE.CUNHA VAZ JG; FONSECA JR; HAGENOUW JRB et al.1977; BRIT. J. OPHTHALMOL.; G.B.; DA. 1977; VOL. 61; NO 6; PP. 399-404; BIBL. 12 REF.Article

Oral vasoactive medication in intermittent claudication : utile or futile?DE BACKER, T. L; STICHELE, R. H. V; WARIE, H. H et al.European journal of clinical pharmacology. 2000, Vol 56, Num 3, pp 199-206, issn 0031-6970Article

Field potential analysis in the freely moving rat during the action of cyclandelate or flunarizineDIMPFEL, W; WEDEKIND, W; SPÜLER, M et al.Pharmacological research. 1992, Vol 25, Num 3, pp 287-297, issn 1043-6618Article

Bioavailability of cyclandelate from capsules in beagle dogs and dissolution rate : correlations with bioavailability in humansKANIWA, N; OGATA, H; AOYAGI, N et al.Journal of pharmacobio-dynamics. 1991, Vol 14, Num 3, pp 152-160, issn 0386-846X, 9 p.Article

Inhibition of acyl coenzyme A : cholesterol acyl transferase by trimethylcyclohexanylmandelate (Cyclandelate)HEFFRON, F; MIDDLETON, B; WHITE, D. A et al.Biochemical pharmacology. 1990, Vol 39, Num 3, pp 575-580, issn 0006-2952Article

Determination of plasma concentrations of cyclandelate and mandelic acid in patients with generalized atherosclerotic vasculopathy trated with oral cyclandelateFORCONI, X; CAPPELI, R; GUERRINI, M et al.Journal of international medical research. 1990, Vol 18, Num 4, pp 266-272, issn 0300-0605, 7 p.Article